Westford, USA, July 26, 2022 (GLOBE NEWSWIRE) -- The cell therapy market is set to grow at an exponential CAGR and will shape patient care in many sectors, and its growth may be reduced only by the inability to control costs. In the last few years, the market has gained an immense popularity for cell therapy across numerous for applications such as cosmetics and transplant. In line with this, the global cell therapy market witnessed a considerable rise in the number of clinical trials undertaken globally. As per SkyQuest analysis, during 2007-2016, more than 251 clinical trials were registered. Wherein, the year 2007, registered the only 3 trials and it went to increase to 116 in 2016. In addition, over 73% of these clinical trials were found to be distributed under non-commercial applications and 26.40 were meant for commercial purpose.
Cell therapy is a rapidly growing field with great potential for treating many diseases including cancer, diabetes, and neurodegenerative diseases. Apart from this, this treatment option has the potential to restore health and improve the quality of life for patients.
In the report published by SkyQuest on Cell Therapy Market, we examine the future of the cell therapy market and related trends innovations that are supporting its growth.
Get sample copy of this report:
https://skyquestt.com/sample-request/cell-therapy-market
Cell Therapy is Ray of Hope for Cancer Patients
Cell therapy is providing hope and healing to cancer patients. This innovative form of treatment is based on reprogramming the cells in the body to fight tumors. Researchers are constantly discovering new ways to target and treat cancer with cell therapy, and it is expected to play an important role in the future of cancer care.
While cell therapy is still relatively new, it has already shown great promise in the treatment of cancer.
Some of the most well-known cell therapies include cancer immunotherapy and adoptive T-cell therapy. Cancer immunotherapy uses the patient's own immune system to fight their cancer. adoptive T-cell therapy works by using T-cells from a donor to help fight the cancer.
The report has explored several active players in the market and how they are performing. One provider that is doing well in the cell therapy industry is OncoCyte Corporation. The company has developed several new therapies that are effective in treating various forms of cancer. OncoCyte currently offers treatments for cervical, lung, and pancreatic cancer. These treatments are reasonably priced, making them a valuable option for patients seeking treatment for their cancer.
Stem Cells is Becoming More Common as a Therapeutic Option
As per SkyQuest Technology, global stem cell therapy market is estimated to grow from $6.87 billion in 2016 to $15.63 billion by 2025. This growth is being driven by the increasing prevalence of disease, rising demand for regenerative medicine, and growing investment in the development of novel cell therapies.
Stem cells are becoming more common as a therapeutic option because they have the ability to become any type of cell in the body. This means that they can be used to treat a wide variety of diseases and injuries. For example, stem cells have been used to successfully treat leukemia and lymphoma. They are also being studied for their potential to treat other types of cancer, Alzheimer's disease, Parkinson's disease, spinal cord injuries, and diabetes.
One of the main drivers of the cell therapy market is the increasing prevalence of diseases such as cancer and neurodegenerative diseases. Cancer is currently the leading cause of death worldwide and killing over 10 million people around the globe every year, and is expected to account for more than half of all deaths by 2030. Cell therapy products that are approved for use in cancer treatment include treatments for leukemia, lung cancer, breast cancer, and several others.
Neurodegenerative diseases are also on the rise, as they are responsible for a large number of disabilities and deaths. Every year, it affects around 2% of the global populated aged 65 and above. Cell therapy products that are approved for use in neurodegenerative disease treatment include treatments for Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis.
Additionally, cell therapy products that are used to regenerate tissue are also driving growth in cell therapy market. These products are not as mature as some of the others in the market, but have exhibited steady growth, and have a chance to further expand. The functionality of cell therapy products extends beyond improving the usability of existing treatment options for cancer, neurodegenerative disease, and other disorders. Employing more effective therapies can offer substantial benefits to those who receive them by reducing pain and improving quality of life.
Despite the promising potential of stem cell therapy, there are still many challenges that need to be addressed before it can become a mainstream treatment option. One of the main challenges is developing an efficient and safe method for delivering stem cells to the target site in the body.
SkyQuest has identified opportunities in stem cell therapy market and how it competing with other available treatment options. The report provider in-depth market analysis, potential opportunities, revenue pockets, company profiles, market dynamics, and current trends.
Browse summary of the report and Complete Table of Contents (ToC):
https://skyquestt.com/report/cell-therapy-market
Regenerative Medicine to Top the Cell Therapy Market
The field of regenerative medicine is one of the most promising and rapidly growing areas in the biomedical sciences. Regenerative medicine focuses on the replacement, repair or regeneration of cells, tissues or organs to restore function in patients with conditions such as heart disease, diabetes and Alzheimer’s disease. Global regenerative cell therapy market is poised to attain a value of $6.9 billion by 2025.
In recent years, cell therapy market has gained immense popularity and emerged as a leading approach in regenerative medicine for treating a wide range of diseases and injuries, including heart disease, stroke, diabetes, Parkinson’s disease and spinal cord injury. As per latest study by SkyQuest, most of the companies offering regenerative cell therapy are located in North America. To be precise, North America is housing around 50% of the global companies active in regenerative cell therapy market. On the other hand, Asia Pacific (27.20%) and Europe (19.30%) are holding second and third largest market share in terms of presence of companies.
The regenerative cell therapy market is expanding at a rapid pace, with investors realizing the potential for this field. In 2021, as per SkyQuest analysis, the market attracted an investment of over $23 billion across gene & gene modified cell therapy, cell therapy, and tissue engineering. However, cell therapy remained the major interest of investors as the segment attracted an investment of more than $12 billion, which is followed by gene and gene modified therapy in 2021. Other major companies include Osiris Therapeutics Inc., and Kite Pharma Ltd. The cell therapy witnessed a significant surge in the investment since 2016, which witnessed an investment of over 1.8 billion, but it went on to grow to $12 billion in 2021. This indicates the how cell therapy market is expanding as more area of application are being explored.
The potential benefits of regenerative cell therapy are vast. The therapies can help treat conditions such as cancer, ALS, diabetes, and heart disease. They can also restore damaged tissues and organs. In addition to treating human patients, Regenerative Medicine Labs is also working on treatments for animals.
Investors are bullish on the potential of this field, with several firms announcing large rounds of funding in recent months. This investment will help drive the development of these therapies further and provide relief to patients worldwide.
SkyQuest has published a new report on cell therapy market that primarily focuses on how the demand for regenerative and stem cell therapy is growing. It dives deep into understanding potential investment pockets, market regulation, analysis of historical investment by sub-segments, opportunities, and market dynamics.
3D Printing is Gaining All the Attention for Custom-Made Implants and Scaffolds for Tissue Regeneration
This little-known technology is capable of engineering 3D scaffolds to allow stem and progenitor cells to proliferate. This has the potential of opening up new possibilities in regenerative cell therapy market such as it can improve the quality of implants and scaffolds. Implant materials are often degraded over time and may need to be replaced. However, with a 3D printer you can create implants using customized templates that are specific to the individual patient’s needs. This means that implants created using a 3D printer can be more durable and longer lasting than those made using traditional methods.
One of the biggest challenges in regenerative cell therapy market is a lack of viable cells that can be used to repair damaged tissue. Wherein, 3D Printed scaffolds could play a role in solving this problem. A 3D printed scaffold is a type of therapeutic device that is used to promote tissue growth. The scaffold is made from layers of biological materials that have been bonded together using a printing process.
The application of 3D printing to tissue regeneration has many benefits. The first advantage is the flexibility of the scaffold. This allows it to conform to the contours of the tissue that it is replacing. Another major benefit of 3D printed scaffolds is their ability to generate multiple copies of the scaffold. This allows for more rapid healing and more accurate reconstruction of the damaged tissue.
Despite these advantages, there are some potential problems with using 3D printed scaffolds in regenerative cell therapy market. One issue is that they can be difficult to print correctly. This can lead to defects in the scaffold that may interfere with its function.
Overall, 3D printed scaffolds have many potential benefits for regenerative medicine. However, there are still some limitations to be addressed before they can be widely adopted by researchers. SkyQuest technology has covered over 100 clinical trials and their potential application in cell therapy market. This would help the companies in understanding current growth opportunities and development in the market.
Speak to Analyst for your custom requirements:
https://skyquestt.com/speak-with-analyst/cell-therapy-market
Increasing Interest in using Natural or “off-the-Shelf” Cells for Cell Therapy Rather than Genetically Modified
The use of natural or “off-the-shelf” cells for cell therapy is an area of increasing interest. The main advantage of using these cells is that they are not genetically modified, which avoids the potential risks associated with genetic modification. Additionally, off-the-shelf cells are readily available and do not require the time and expense of creating a custom cell line for each patient.
There are several types of off-the-shelf cells that have been investigated in the cell therapy market, including mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), and embryonic stem cells (ESCs). MSCs can be easily isolated from adult tissue and expanded in culture, making them a readily available source of therapeutic cells. iPSCs can be generated from a patient’s own skin or blood Cells, meaning they would be immune-compatible with the recipient and would not require immune suppression. ESCs are derived from early-stage embryos and have the ability to differentiate into any cell type in the body; however, their use is limited by ethical concerns.
Prominent Players in Cell Therapy Market
- Thermo Fisher Scientific Inc. (US)
- Merck KGaA (Germany)
- MaxCyte (US)
- Danaher Corporation (US)
- Becton, Dickinson, and Company (US)
- Lonza Group (Switzerland)
- Sartorius AG (Germany)
- Terumo BCT (US)
- Fresenius Medical Care AG & Co. KGaA (Germany)
- Avantor, Inc. (US)
- Bio-Techne Corporation (US)
- Corning Incorporated (US)
- FUJIFILM Irvine Scientific (US)
- MaxCyte (US)
Related Reports in SkyQuest’s Library:
Global Synthetic Biology Market
About Us:
SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.
Address:
1 Apache Way, Westford, Massachusetts 01886
Phone:
USA (+1) 617-230-0741
Email: sales@skyquestt.com
